Metabolic syndrome and liver disease in the era of bariatric surgery: What you need to know!
作者机构:Aristotle University School of MedicineThessaloniki 54124Greece Center for Health Innovations and Outcomes Research(CHIOR)The Feinstein Institute for Medical ResearchManhassetNY 11030United States The First Department of SurgeryAristotle University of ThessalonikiThessaloniki 54124Greece
出 版 物:《World Journal of Hepatology》 (世界肝病学杂志(英文版)(电子版))
年 卷 期:2020年第12卷第10期
页 面:709-721页
学科分类:1002[医学-临床医学] 100210[医学-外科学(含:普外、骨外、泌尿外、胸心外、神外、整形、烧伤、野战外)] 10[医学]
主 题:Metabolic syndrome Bariatric surgery Sleeve gastrectomy Gastric bypass Non-alcoholic fatty liver disease Non-alcoholic steatohepatitis Liver transplantation
摘 要:Metabolic syndrome(MS)is defined as the constellation of obesity,insulin resistance,high serum triglycerides,low high-density lipoprotein cholesterol,and high blood *** increasingly affects more and more people and progressively evolves into a serious issue with widespread healthcare,cost,and quality of life associated *** is associated with increased morbidity and mortality due to cardiovascular or chronic liver *** treatment,which includes diet,exercise,and antidiabetic agents,is the mainstay of treatment,but depends on patient compliance to medical treatment and adherence to lifestyle modification *** surgery has recently emerged as an appropriate alternative treatment with promising longterm *** gastrectomy and Roux-en-Y gastric bypass constitute the most commonly performed procedures and have been proven both cost-effective and safe with low complication *** transplantation is the only definitive treatment for end-stage liver disease and its utilization in patients with nonalcoholic steatohepatitis has increased more than fivefold over the past 15 *** this review,we summarize current state of evidence on the surgical treatment of MS.